• Return to Headlines

Relatively Low Revenue Per Employee Detected in Shares of Repros Therapeutics in the Pharmaceuticals Industry (RPRX, XNPT, SCLN, MYL, CRME)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the lowest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Repros Therapeutics ranks lowest with a an RPE of $77. XenoPort is next with a an RPE of $225,000. Sciclone Pharmaceuticals ranks third lowest with a an RPE of $240,000.

Mylan follows with a an RPE of $301,000, and Cardiome Pharma rounds out the bottom five with a an RPE of $356,000.

SmarTrend recommended that subscribers consider buying shares of Sciclone Pharmaceuticals on November 9th, 2015 as our technology indicated a new Uptrend was in progress when shares hit $7.98. Since that recommendation, shares of Sciclone Pharmaceuticals have risen 72.8%. We continue to monitor Sciclone Pharmaceuticals for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest revenue per employee repros therapeutics xenoport sciclone pharmaceuticals Mylan cardiome pharma